Page 3 - Csir

Regulatory nod given to conduct clinical trials of Colchicine: CSIR

The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct clinical trial of Colchicine on COVID-19 patients, according to a statement on Saturday. Ram Vishwakarma, the advisor to the CSIR Director General, said Colchicine in combination with standard care will be an important therapeutic intervention for COVID-19 patients with cardiac co-morbidities and also for reducing pro-inflammatory cytokines, leading to faster recovery. A number of global studies have confirmed that cardiac complications during course of COVID-19 infections and post-Covid syndrome are leading to loss of many lives, and it is essential to look for new or repurposed drugs, he said. "Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt Ltd Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine in improvement of

Bharat Biotech, CSIR collaborate to make raw material for vaccines

India now imports adjuvants and other chemicals for vaccine manufacturing

India Coronavirus Dispatch: Second Covid wave inevitable, say experts

Experts on a second wave, contribution to global Covid research, vaccination programme takes a pause, and more-news relevant to India's fight against Covid-19

BEML, NAL sign MoU to jointly develop 2-seater trainer aircraft

BEML Limited has signed an MoU with Council of Scientific and Industrial Research (CSIR)-National Aerospace Laboratories (NAL) for joint development in the areas of advanced composites and autoclaves, mini-unmanned aerial vehicles, design & analysis of aircraft structure and systems. BEML also teamed with NAL for joint development of two seater trainer aircraft through transfer of technology, according to a BEML statement. "This will help BEML increase its footprint in the aerospace sector," the statement said.

CCMB to assess Ayurveda formulations' efficacy against coronavirus

Standardised Ayurveda formulations provided by AVS in Kottakkal would be tested on the lab-grown coronavirus in the cell culture system, the premier research institute here said on Friday

CSIR NET Result 2020 out on csirnet.nta.nic.in: Here's how to check scores

CSIR NET Result: CSIR UGC NET 2020 June result 2020 has been released by NTA and is now available on csirnet.nta.nic.in. Here's all you need to know

Vaccine will be equally effective against new coronavirus strain: CSIR DG

Indian institutions have sequenced over 4,000 genomes of the coronavirus and submitted to the Global Initiative on Sharing All Influenza Data

Union Min Harsh Vardhan launches CSIR technologies for rural development

The technologies were launched under a joint initiative of CSIR, Unnat Bharat Abhiyan (UBA), Indian Institute of Technology Delhi (IITD) and Vijnana Bharti (VIBHA)

CSIR, Mylan to collaborate to identify advance therapeutic ways for Covid

The Council of Scientific and Industrial Research (CSIR) and Mylan Laboratories Limited will collaborate to identify potential therapies for COVID-19, the country's premier research body said in a statement on Wednesday. A series of clinical trials will be conducted towards new and innovative solutions to manage the COVID-19 pandemic in India as part of this collaboration. The first of the clinical trials to be rolled out is a multiple-arm phase 3 study that will be conducted in adult patients with mild to moderate COVID-19 at risk of complications, it said. "The Council of Scientific & Industrial Research (CSIR), India's premier research organisation, and Mylan Laboratories Limited, the India-based subsidiary of leading global pharmaceutical company Mylan, today announced a partnership to address unmet patient needs amidst the evolving COVID-19 pandemic," according to the statement. "Under the partnership, CSIR's constituent laboratory Indian Institute of Chemical Technology ...

CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines

The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.As per the release issued by the Centre for Cellular & Molecular Biology (CCMB), under the signed agreement between CSIR- CCMB and Aurobindo Pharma, Aurobindo will partner with CSIR for the development of several novel COVID-19 vaccines."Three CSIR labs namely CCMB Hyderabad, Institute of Medical Technology (IMTECH), Chandigarh and Indian Institute of Chemical Biology (IICB), Kolkata are developing vaccine candidates using different technology platforms. Aurobindo will undertake clinical development and commercialization of the vaccines," it said.Commenting on this partnership, Dr Shekhar C Mande, Director General, CSIR, said that "Joining of hands of premier CSIR labs with industry for the development of vaccines will amplify India's efforts in indigenous vaccine development and also help in preparedness for future ...

Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR

Developing own candidate; to develop and make CSIR vaccine candiates

CSIR, FSSAI sign MoU for collaborative research on food and nutrition

Vardhan highlighted that the country will see a surge in demand for healthy, nutritious, plant-based, local, seasonal and indigenous foods, produced organically

CSIR scientists design oxygen enrichment unit for homes, hospitals: Vardhan

Scientists at CSIR have designed an oxygen enrichment unit that can be used in homes, hospitals and remote rural areas and can prove to be very important in COVID-19 times, Union Health Minister Harsh Vardhan said on Monday. He said the unit can help reduce the demand for oxygen cylinders and ventilators. "Scientists at the CSIR (Council of Scientific & Industrial Research)-National Chemical Laboratory, Pune have designed an oxygen enrichment unit that can be used when needed in homes, hospitals and remote rural areas. This can prove to be very important in the COVID times," he said in a tweet. "One of its features is that it does not require #oxygen cylinder. This unit may help reduce the demand for oxygen cylinders and ventilators. If #COVID19patients get oxygen initially, they do not need ventilators later. @IndiaDST," Vardhan said in another tweet.

Cadila-CSIR's sepsis drug shows promise in fight against Covid-19

The public-private partnership trial-generated data will be soon presented before the country's drug regulator to see if it can get emergency-use authorisation.

Covid-19: CSIR gets nod for phase III trials of antiviral drug Umifenovir

Umifenovir is mainly used for treatment of influenza and is available in China and Russia, and has recently come into prominence due to its potential use for Covid19 patients

Trust ICMR call on HCQ in Covid treatment: CSIR's Shekhar Mande

Indian researchers have not found any major side-effects of HCQ and its use should be continued in preventive treatment for Covid-19, ICMR said

India gears up for patient trials on 20 different drugs for Covid-19

Local pharma units have already started work on developing patented drugs, some have already approached regulator for approvals

CSIR NET Result 2019 declared on csirnet.nta.nic.in; know details

CSIR NET Result: Two separate merit lists were declared by NTA today on csirnet.nta.nic.in and nta.nic.in

CSIR NET Result 2019 out on csirnet.nta.nic.in: Get direct download link

CSIR NET Result: The UGC NET exam 2019 was conducted for chemical sciences, earth atmospheric ocean and planetary science, life science, mathematical sciences and physical sciences

CSIR NET Result 2019 to be declared soon: Steps to download marks here

CSIR NET Result 2019: A total of 282,116 candidates applied from across the country to appear for the CSIR NET